Details
Stereochemistry | ACHIRAL |
Molecular Formula | C40H38F5N3O3S |
Molecular Weight | 735.805 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C(SCC5=C(F)C(F)=CC=C5)=CC(=O)C6=C4C=CC=C6
InChI
InChIKey=NNBGCSGCRSCFEA-UHFFFAOYSA-N
InChI=1S/C40H38F5N3O3S/c1-51-22-21-46-19-17-32(18-20-46)47(24-27-9-11-28(12-10-27)29-13-15-31(16-14-29)40(43,44)45)37(50)25-48-35-8-3-2-6-33(35)36(49)23-38(48)52-26-30-5-4-7-34(41)39(30)42/h2-16,23,32H,17-22,24-26H2,1H3
Molecular Formula | C40H38F5N3O3S |
Molecular Weight | 735.805 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Rilapladib (SB659032) is a potent and selective inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2). Inhibition of Lp-PLA2 can reduce peripheral measures of inflammation. Rilapladib has been evaluated for treatment in Alzheimer’s disease and atherosclerosis. Initial results from clinical trials in Alzheimer patients suggests that oral administration of rilapladib may slow down the progression of Alzheimer’s disease. Initial evidence has also been found that inhibition of Lp-PLA2 may attenuate intimal macrophage accumulation and consequently stabilize atherosclerotic plaque.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Lipoprotein-associated phospholipase A(2) and atherosclerosis. | 2009 Oct |
|
Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study. | 2012 |
|
Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. | 2014 Aug |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:31:10 GMT 2023
by
admin
on
Fri Dec 15 16:31:10 GMT 2023
|
Record UNII |
O14CWE893Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C76401
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
8704
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
O14CWE893Z
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
9918381
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
SUB64595
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104981
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
DB05119
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
412950-08-4
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
100000134795
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
DTXSID50194281
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY | |||
|
RR-58
Created by
admin on Fri Dec 15 16:31:10 GMT 2023 , Edited by admin on Fri Dec 15 16:31:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|